期刊文献+

局部晚期宫颈癌CT图像引导下^192Ir三维腔内后装治疗剂量体积参数与疗效关系 被引量:18

The correlation between DVH at CT-image based 192Ir intracavitary brachytherapy and effects or complications for patients with locally advanced cervical cancer
原文传递
导出
摘要 目的 观察CT图像引导下^192Ir三维腔内后装治疗的肿瘤靶区及危及器官受照射体积剂量参数与肿瘤局部控制率及晚期副反应之间关系.方法 10例局部晚期宫颈癌患者在完成盆腔外照射40 Gy及同期化疗后开始每周1次的CT图像引导下^192Ir三维腔内后装治疗,每次治疗前进行CT扫描定位,勾画肿瘤靶区(GTV、CTV)和危及器官,利用PLATO治疗计划系统进行逆向治疗计划设计及优化,CTV单次处方剂量为6 Gy,治疗5~7次.结果 1年盆腔控制率为90%,1~2级放射性肠炎发生率为50%,无≥3级副反应.90%CTV等效生物剂量(BED)和相当于2 Gy分次的等效剂量(EQD2)分别为(95.50±7.81)Gy和(79.73±6.57)Gy(α/β=10).90%GTV的BED和EQD2分别为(101.86±7.27)Gy和(84.95±6.1)Gy(α/β=10).90%处方剂量对GTV、CTV的覆盖率分别为92%±4%、87%±7%.直肠、乙状结肠2 cm^3体积受到的最小照射剂量分别为(74.97±1.64)、(67.93±4.30)Gy(EQD2,α/β=3).与二维治疗计划相比,三维治疗计划在没有改变A点剂量、直肠参考点剂量情况下提高了GTV、CTV的90%体积受照射剂量及90%处方剂量对GTV、CTV的覆盖率.结论 CT图像引导下192Ir三维腔内后装治疗提高了处方剂量对肿瘤靶区的覆盖率,1年盆腔控制率为90%且无严重副反应,远期疗效观察中. Objective To investigate the correlation between dose volume histogram(DVH)of tumor targets and organs at risk(OAR)at CT-image based 192Ir brachytherapy and effects and complications for patients with locally advanced cervical cancer. Methods Ten patients with FIGO stage ⅢB cervical cancer received CT image-based 192Ir intracavitary brachytherapy after 54 Gy of three-dimentional four-field pelvic external beam radiotherapy and concurrent weekly cisplatin chemotherapy. Before each brachytherapy,CT images were acquired with applicators in place. Gross tumor volume(GTV), clinical target volume (CTV)and OAR were contoured and inverse treatment planning was designed and optimized by using PLATO treatment planning system. Conventional two-dimensional plans were also designed for comparison.The total intracavitary brachytherapy dose was 30 -42 Gy in 5 -7 fractions. The patients were followed, and the local control and complications were analyzed. The biologically equivalent dose(BED)and biologically equivalent dose in 2 Gy fractions(BED2)for GTV, CTV and OAR were calculated. The minimum dose in the most irradiated tissue volume 2 cm3(D2 cm3)adjacent to the applicator of the sigmoid colon, rectum,bladder and small bowel was determined from the DVH. Results The 1-year local pelvic control rate was 90% and grade 1-2 late complication of sigmoid colon and rectum was 50%. No grade 3 or more complications developed. On CT-image based planning, the BED and BED2 to 90% of the CTV(D90)were 95.50 Gy ± 7. 81 Gy and 79. 73 Gy ± 6. 57 Gy. The BED and BED2 to 90% of the GTV(D90)were 101.86 Gy ± 7.27 Gy and 84. 95 Gy ± 6. 1 Gy. The volume enclosed by 90% of prescribed dose(V90)for GTV and CTV were 92% ±4% and 87% ±7% respectively. The D2cm3 for rectum and sigmoid colon were 74. 97 Gy ±1.64 Gy and 67. 93 Gy ± 4. 30 Gy(EQD2, α/β = 3). Comparing with 2D brachytherapy plans , CT - image based planning has improved D90 and V90 for GTV and CTV with similar dose at point A and rectum reference point. Conclusions Computer tomography-image based 192Ir brachytherapy has resulted in the better dose distribution to the tumor targets with excellent tumor control and acceptable toxicity.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2011年第1期49-53,共5页 Chinese Journal of Radiation Oncology
基金 基金项目:国家自然科学基金资助项目(30770635)
关键词 宫颈肿瘤 局部晚期/近距离疗法 CT图像引导 剂量体积直方图参数 宫颈肿瘤 局部晚期/放化疗法 治疗结果 Cervical neoplasms, locally advanced/brachytherapy CT-image based Dose volume histogram parameter Cervical neoplasms, locally advanced/radiochemotherapy Treatment outcome
  • 相关文献

参考文献19

  • 1Rose PG,Bundy BN,Watkins EB,et al.Concurrent cisplatinbased radiotherapy and chemotherapy for locally advanced cervical cancer.N Engl J Med,1999,340:1144-1153.
  • 2Whitney CW,Sause W,Bundy BN,et al.Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage ⅡB-ⅣA carcinoma of the cervix with negative para-aortic lymph nodes:a gynecologic oncology group and southwest oncology group study.J Clin Oncol,1999,17:1339-1348.
  • 3Rose PG,Ali S,Watkins E,et al.Gynecologic Oncology Group.Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin,cisplatin-based combination chemotherapy,or hydroxyurea during pelvic irradiation for locally advanced cervical cancer:a gynecologic oncology group study.J Clin Oncol,2007,25:2804-2810.
  • 4Haie-Meder C,P(o)tter R,Van Limbergen E,et al.Gynaecological (GYN)GEC-ESTRO working group.Recommendations from gynaecological(GYN)GEC-ESTRO working group(Ⅰ):concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.Radiother Oncol,2005,74:235-245.
  • 5P(o)tter R,Haie-Meder C,Van Limbergen E,et al.GEC ESTRO working group.Recommendations from gynaecological(GYN)GEC ESTRO working group(Ⅱ):concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy,radiation physics,radiobiology.Radiother Oncol,2006,78:67-77.
  • 6Viswanathan AN,Erickson BA.Three-dimensional imaging in gynecologic brachytherapy:a survey of the American brachytherapy society.Int J Radiat Oncol Biol Phys,2010,76:104-109.
  • 7Shin KH,Kim TH,Cho JK,et al.CT-guided intracavitary radiotherapy for cervical cancer:comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.Int J Radiat Oncol Biol Phys,2006,64:197-204.
  • 8Dimopoulos JC,P(o)tter R,Lang S,et al.Dose-effect relationship for local control of cervical cancer by magnetic resonance imageguided brachytherapy.Radiother Oncol,2009,93:311 -315.
  • 9Kim RY,Pareek P.Radiography-based treatment planning compared with computed tomography(CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix:analysis of dose-volume histograms.Brachytherapy,2003,2:200-206.
  • 10Lindegaard.JC,Tanderup K,Nielsen SK,et al.MRI-guided 3D optimization significantly improves DVH parameters of pulsed-doserate brachytherapy in locally advanced cervical cancer.Int J Radiat Oncol Biol Phys,2008,71:756-764.

同被引文献112

引证文献18

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部